Search

Search results

215 results found

[Sample] Temporal Frontiers: An Examination of Time in Literature and Philosophy

Class

This course is a unique exploration of how time is perceived, portrayed, and questioned in literature and philosophy. Readings will span a wide spectrum from Proust's reflective introspections to Einstein's theoretical physics. By exploring the varied interpretations of time in different cultural...

A novel orthotopic mouse model of human anaplastic thyroid carcinoma.

Publication: Journal Article

Nucera, Carmelo, Matthew A Nehs, Michal Mekel, Xuefeng Zhang, Richard Hodin, Jack Lawler, Vania Nose, and Sareh Parangi. 2009. “A Novel Orthotopic Mouse Model of Human Anaplastic Thyroid Carcinoma.”. Thyroid : Official Journal of the American Thyroid Association 19 (10): 1077-84.

ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.

Publication: Journal Article

Greenaway, James, Jack Henkin, Jack Lawler, Roger Moorehead, and Jim Petrik. 2009. “ABT-510 Induces Tumor Cell Apoptosis and Inhibits Ovarian Tumor Growth in an Orthotopic, Syngeneic Model of Epithelial Ovarian Cancer.”. Molecular Cancer Therapeutics 8 (1): 64-74.

Thrombospondins.

Publication: Journal Article

Lawler, Jack. 2008. “Thrombospondins.”. Current Drug Targets 9 (10): 820-1.

Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan.

Publication: Journal Article

Chen, Faye Hui, Mary E Herndon, Nichlesh Patel, Jacqueline T Hecht, Rocky S Tuan, and Jack Lawler. 2007. “Interaction of Cartilage Oligomeric Matrix Protein/Thrombospondin 5 With Aggrecan.”. The Journal of Biological Chemistry 282 (34): 24591-8.

Vascular response to intra-arterial injury in the thrombospondin-1 null mouse.

Publication: Journal Article

Budhani, Faisal, Katherine A Leonard, Andreas Bergdahl, Jimin Gao, Jack Lawler, and Elaine C Davis. 2007. “Vascular Response to Intra-Arterial Injury in the Thrombospondin-1 Null Mouse.”. Journal of Molecular and Cellular Cardiology 43 (2): 210-4.

Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.

Publication: Journal Article

Zhang, Xuefeng, Jianfeng Xu, Jack Lawler, Ernest Terwilliger, and Sareh Parangi. 2007. “Adeno-Associated Virus-Mediated Antiangiogenic Gene Therapy With Thrombospondin-1 Type 1 Repeats and Endostatin.”. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 13 (13): 3968-76.

Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1).

Publication: Journal Article

Greenaway, James, Jack Lawler, Roger Moorehead, Paul Bornstein, Jonathan Lamarre, and Jim Petrik. 2007. “Thrombospondin-1 Inhibits VEGF Levels in the Ovary Directly by Binding and Internalization via the Low Density Lipoprotein Receptor-Related Protein-1 (LRP-1).”. Journal of Cellular Physiology 210 (3): 807-18.

Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.

Publication: Journal Article

Bonnefoy, Arnaud, Kim Daenens, Hendrik B Feys, Rita De Vos, Petra Vandervoort, Jos Vermylen, Jack Lawler, and Marc F Hoylaerts. 2006. “Thrombospondin-1 Controls Vascular Platelet Recruitment and Thrombus Adherence in Mice by Protecting (sub)endothelial VWF from Cleavage by ADAMTS13.”. Blood 107 (3): 955-64.

Characterization of integrin beta6 and thrombospondin-1 double-null mice.

Publication: Journal Article

Ludlow, Anna, Karen O Yee, Ruth Lipman, R Bronson, P Weinreb, Xiaozhu Huang, D Sheppard, and J Lawler. 2005. “Characterization of Integrin Beta6 and Thrombospondin-1 Double-Null Mice.”. Journal of Cellular and Molecular Medicine 9 (2): 421-37.